- Home
- ARCT vs IRMD Comparison
ARCT vs IRMD Comparison
Compare ARCT & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- IRMD
- Stock Information
- Founded
- ARCT 2013
- IRMD 1992
- Country
- ARCT United States
- IRMD United States
- Employees
- ARCT N/A
- IRMD N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- IRMD Medical/Dental Instruments
- Sector
- ARCT Health Care
- IRMD Health Care
- Exchange
- ARCT Nasdaq
- IRMD Nasdaq
- Market Cap
- ARCT 487.0M
- IRMD 737.7M
- IPO Year
- ARCT N/A
- IRMD 2014
- Fundamental
- Price
- ARCT $17.98
- IRMD $56.62
- Analyst Decision
- ARCT Strong Buy
- IRMD Strong Buy
- Analyst Count
- ARCT 7
- IRMD 1
- Target Price
- ARCT $65.00
- IRMD $60.00
- AVG Volume (30 Days)
- ARCT 422.7K
- IRMD 48.6K
- Earning Date
- ARCT 03-06-2025
- IRMD 02-06-2025
- Dividend Yield
- ARCT N/A
- IRMD 1.06%
- EPS Growth
- ARCT N/A
- IRMD 13.16
- EPS
- ARCT N/A
- IRMD 1.46
- Revenue
- ARCT $160,399,000.00
- IRMD $71,305,130.00
- Revenue This Year
- ARCT $7.33
- IRMD $13.29
- Revenue Next Year
- ARCT $4.71
- IRMD $10.76
- P/E Ratio
- ARCT N/A
- IRMD $38.76
- Revenue Growth
- ARCT N/A
- IRMD 13.23
- 52 Week Low
- ARCT $14.30
- IRMD $40.18
- 52 Week High
- ARCT $45.00
- IRMD $58.41
- Technical
- Relative Strength Index (RSI)
- ARCT 51.50
- IRMD 63.54
- Support Level
- ARCT $16.01
- IRMD $55.35
- Resistance Level
- ARCT $21.26
- IRMD $58.41
- Average True Range (ATR)
- ARCT 1.36
- IRMD 1.53
- MACD
- ARCT 0.34
- IRMD 0.31
- Stochastic Oscillator
- ARCT 52.87
- IRMD 83.02
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.